Press

855-HOW-TO-QUIT-(OPIOIDS) is an initiative to fight the opioid epidemic, by turning the object of addiction into a way out. The helpline uses the imprint codes of the most common opioid pills as phone extensions, connecting those who struggle with addiction to those who managed to quit. We developed this project together with a coalition of NGOs, healthcare providers, communication experts, artists, and activists, and open to anyone who wishes to join the fight. Learn more at 855-how-to-quit.org If you’re struggling with addiction, call 855-469-86-7848 followed by any imprint code.

The Journal of Applied Biomedicine will publish AIZOME seminal research on the skin-healing properties of plant-derived indigo in December 2022. Together with research from the University of Cambridge (UK) and the University of Sharjah (UAE) AIZOME has undertaken the endeavor to demystify such agents and clearly indicate viable alternative topical steroids.

Together with Professor Dr. Wilhelm Schwaeble and Dr. Youssif M. Ali, both from Cambridge University, Aizome conducted a groundbreaking study of natural indigo dye on highly inflamed skin lesions to assess the effects on sensitive skin. The study is ongoing and the results will be published later this year.

Anzen Health commenced work with the Seed Research Institute to find novel chemical compounds for commercialization in the wake of growing antibiotics resistance.

Anzen Health became an exclusive distributor for Quadrant Bioscience, which developed the most accurate Saliva PCR test to detect Covid-19, even in the earliest stages. Anzen will offer the test to clients in the US, Europe, and Japan.

Anzen Health, together with their partner Aizome, created “Turtle Beach Clean,” a Japanese NGO that focuses on direct action to rid highly polluted beaches of plastic trash in order to secure breeding grounds for marine animals, such as sea turtles

Anzen’s venture partner, Aizome, became a member of the BVN (German National Association of Neurodermatitis) as a partner, helping to reduce the suffering of people with chronic skin conditions.

Anzen Health donated 30,000 masks to Syracuse in New York through Upstate Medical University Hospital.

Anzen Health donated 30,000 masks to Syracuse in New York through Upstate Medical University Hospital.

Anzen Health donated 20,000 masks to Koch-Ebersperger-Stiftung, who helps homeless people in Southern Germany.

Anzen’s venture Aizome won serviceplan as partner. Serviceplan is Europe's largest private PR agency. “We are convinced that Aizome is an innovative gem. Together we will be able to take the world by storm.” -- Franz Roeppischer, Executive Creative Director at Serviceplan Group

With growing demand from European customers, Anzen’s venture Aizome opened Aizome Europe, which will begin serving customers in Germany and later countries throughout Europe.

Anzen Health donated funds and helped to fulfill mask donations to schools in both New York and California.

As the first relevant bedding product, Aizome received the National Eczema Association seal of approval as an innovation that helps people with skin diseases to live a more comfortably.

The venture Aizome Bedding was nominated by the Green Product Award as an innovation that has the potential to transform the textile industry.

As a reaction to the unfolding pandemic, Anzen Health utilized its supply chain expertise to offer B2B service for branded personal protection items for healthcare networks and hospitals around the world. “I can’t say I have ever been excited about a partnership with a PPE supplier. I am now! (...) I have given (Anzen) countless recommendations to colleagues and friends.” -- Prof. Mantosh Dewan, President, Upstate Medical

Incorporation of Aizome Beeding, Anzen’s first venture. “After becoming Japan's most successful crowdfunded company, we partnered with Anzen to take over the US market,” said Jun Sugita, COO of Aizome. Aizome will have a B2C portal for bed sheets on aizomebedding.com and a B2B portal to assist other companies in developing their own 100% plant-based herbal textiles.

Anzen partnered with Nippon Zoki, a prestigious drug manufacturer in Japan, on their accelerator program “Tomorrow Lab,” which promises to give birth to new digital ventures that transform chronic pain treatments. “We partnered with Anzen for their expertise in design, creativity, and a supreme understanding of healthcare innovations.” -- Chihiro Konish, Director BDM at Nippon Zokki

Anzen Health was created by founder Michel May with the vision to change healthcare with their by enabling clients to optimize, modernize, save money, and focus on what matters: the patient.